Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $373,850 - $427,350
-5,000 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$71.87 - $131.03 $718,700 - $1.31 Million
-10,000 Reduced 66.67%
5,000 $380,000
Q2 2020

Aug 14, 2020

BUY
$79.55 - $124.22 $715,950 - $1.12 Million
9,000 Added 150.0%
15,000 $1.85 Million
Q3 2019

Nov 14, 2019

BUY
$67.4 - $85.11 $404,400 - $510,660
6,000 New
6,000 $404,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Highland Capital Management Fund Advisors, L.P. Portfolio

Follow Highland Capital Management Fund Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.